About 220 results

ALLMedicine™ Hyperamylasemia Center

Research & Reviews  78 results

Serum amylase elevation is associated with adverse clinical outcomes in patients with c...
Aging Li G, Liu T et. al.

Oct 30th, 2021 - Hyperamylasemia was found in a group of patients with COVID-19 during hospitalization. However, the evolution and the clinical significance of hyperamylasemia in COVID-19, is not well characterized. In this retrospective cohort study, the epidemio...

Early postoperative serum hyperamylasemia: Harbinger of morbidity hiding in plain sight?
Surgery McGuire SP, Maatman TK et. al.

Aug 26th, 2021 - The clinical significance of postoperative serum pancreatic enzyme elevation after pancreatoduodenectomy is understudied. We hypothesized that elevation in serum enzymes predicts morbidity and mortality after pancreatoduodenectomy. Retrospective r...

Conjugated Hyperbilirubinemia in Infants: Is There Still a Role for ERCP?
Canadian Journal of Gastroenterology & Hepatology; Stovicek J, Hlava S et. al.

Jul 15th, 2021 - Over a twenty-year period, we performed 255 ERCP procedures in infants aged up to 1 year. ERCP was indicated in cholestatic infants with suspicion of biliary obstruction. The most common diagnosis was biliary atresia (48%), choledochal cysts (13%)...

Aggressive hydration with lactated ringer solution in prevention of post-endoscopic ret...
Medicine Wu M, Jiang S et. al.

Apr 22nd, 2021 - Acute pancreatitis is the most common complication of Endoscopic Retrograde Cholangiopancreatography (ERCP). There was no conclusion on the prevention of Post-ERCP Pancreatitis (PEP) by Lactated Ringer Solution. The purpose of this meta analyses i...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  4 results

7 cm vs. 5 cm Pancreatic Stents for the Prevention of Post-ERCP Pancreatitis in High-risk Patients

Oct 30th, 2019 - Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). The incidence of post-ERCP pancreatitis (PEP) is estimated to be 10% to 15% in high-risk patients. Current guidelines recommend using panc...

A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis

Aug 5th, 2016 - Postendoscopic retrograde cholangiopancreatography pancreatitis is the most frequent and serious complication of ERCP procedures, occurring in approximately 5-15% of unselected patients. Pharmacologic prevention of post-ERCP pancreatitis has been ...

Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients

Sep 22nd, 2015 - Hypothesis: Diclofenac, when administered immediately post ERCP in patients at higher risk of developing post-ERCP pancreatitis, will significantly reduce the incidence of this complication. Intervention: All patients undergoing ERCP not having ex...

Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)

Jan 29th, 2009 - Acute pancreatitis represents the most common complication after ERCP. The reported incidence of this complication varies from less than 1% to 40%, but rates of about 10% are reported in most prospective studies involving non-selected patients. Al...

see more →

News  5 results

Experts Grapple With Nuances of Navigating New Frontier in Melanoma

Dec 5th, 2020 - Keith T. Flaherty, MD Emerging data showing improved survival with targeted and immunotherapeutic approaches are rapidly altering the standard of care for patients with melanoma. For BRAF-positive patients with metastatic or unresectable melanoma...

COVID-associated pancreatitis may disproportionately affect young, overweight men
Will Pass

Jun 24th, 2020 - Patients with COVID-19 develop a distinct subset of pancreatitis hallmarked by duodenal and periduodenal inflammation, according to a recent case series. Although all five patients presented with multiple predictive markers of severe pancreatitis,.

FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB

Aug 14th, 2019 - The US Food and Drug Administration (FDA) approved pretomanid today, a "major" breakthrough treatment for the most drug-resistant tuberculosis (TB) when used in combination with bedaquiline and linezolid. It is only the third TB drug approved by t...

Criteria for Cadaveric Pancreas Donation

Sep 9th, 2004 - Question What are the acceptable donor criteria for cadaveric pancreas donation? F.R. Calder, Mb ChB Response from Robert J. Stratta, MD Donor selection and organ procurement are paramount to the success of pancreas transplantation. Most heart-bea...

Donor Selection for Pancreas Transplantation?

Mar 27th, 2001 - Question What are the donor exclusion criteria, with special reference to fatty pancreas, for pancreas transplantation? Santosh Potdar, MD Response from Robert J. Stratta, MD Donor selection and organ procurement are of paramount importance to the...

see more →